Sainz Maria
Transaction: 06/11/2026
BUY
Change
+3,793
Price
$26.89
Filing
06/15/2026
Type
BUY
Pulse Biosciences, Inc.
PLSE • Medical - Instruments & Supplies
$50.12
▼ -0.72 (-1.42%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$3.34B
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.09Healthy liquidity · 10.53Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 1:01 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$50.12
Change-1.42%
Shares Out69.20M
Market Cap$3.34B
Enterprise Value$3.24B
52W Range12.56 - 39.05
Beta1.65
P/E-41.67
P/S2,815.30
P/B33.53
P/FCF-43.89
EV/Sales2,735.26
Price$50.12
Change-1.42%
Shares Out69.20M
Market Cap$3.34B
Enterprise Value$3.24B
52W Range12.56 - 39.05
Beta1.65
P/E-41.67
P/S2,815.30
P/B33.53
P/FCF-43.89
EV/Sales2,735.26
EV/EBITDA-40.75
EV/FCF-42.64
Earnings Yield-2.40%
FCF Yield-2.28%
Dividend Yield0.00%
Gross Margin-3.60%
Oper. Margin-219.83%
Profit Margin-207.95%
Debt/Eq0.09
Current Ratio10.53
Quick Ratio10.51
Target$60.20
Target Upside20.11%
Target Median$58.00
Target Range55.00 - 70.00
Volume266.63K
Avg Volume346.65K
EPS Surprise0.05
Investment DNA
How strong this company looks for long-term investors
29
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
20/100
Why this score▼
Manageable debt level · 0.09Healthy liquidity · 10.53Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 6 analyst votes · 2026-10-20
83/100
Bullish
Bullish
4
Hold
2
Bearish
0
Price Target
2026-08-07
Low
$32.00
Mean
$33.50
Median
$33.50
High
$35.00
Insider Transactions
Recent executive and insider activity
Soni Manmeet Singh
Transaction: 06/11/2026
BUY
Change
+30,000
Price
$26.89
Filing
06/15/2026
Type
BUY
DUGGAN ROBERT W
Transaction: 06/11/2026
BUY
Change
+12,495
Price
$26.89
Filing
06/15/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Sainz Maria | BUY | +3,793 | $26.89 | 06/11/2026 | 06/15/2026 |
| Soni Manmeet Singh | BUY | +30,000 | $26.89 | 06/11/2026 | 06/15/2026 |
| DUGGAN ROBERT W | BUY | +12,495 | $26.89 | 06/11/2026 | 06/15/2026 |
| van den Broek Richard | BUY | +8,423 | $26.89 | 06/11/2026 | 06/15/2026 |
| Zanganeh Mahkam | BUY | +14,504 | $26.89 | 06/11/2026 | 06/15/2026 |
| DUGGAN ROBERT W | BUY | +660,233 | $19.69 | 05/11/2026 | 05/15/2026 |
| DUGGAN ROBERT W | BUY | +660,233 | $19.69 | 05/11/2026 | 05/11/2026 |
| LAVIOLETTE PAUL A | BUY | +15,000 | $19.69 | 05/11/2026 | 05/11/2026 |
| UECKER DARRIN | BUY | +100,000 | Not reported | 03/23/2026 | 04/03/2026 |
| Danahy Kevin Patrick | SELL | -5,000 | $23.64 | 02/18/2026 | 02/23/2026 |
| Danahy Kevin Patrick | SELL | -5,000 | $1.53 | 02/18/2026 | 02/23/2026 |
| Danahy Kevin Patrick | SELL | -20,000 | $23.63 | 02/17/2026 | 02/17/2026 |
| Danahy Kevin Patrick | SELL | -20,000 | $1.53 | 02/17/2026 | 02/17/2026 |
| Danahy Kevin Patrick | SELL | -20,000 | $23.53 | 02/13/2026 | 02/17/2026 |
| Danahy Kevin Patrick | SELL | -20,000 | $1.53 | 02/13/2026 | 02/17/2026 |
| Danahy Kevin Patrick | SELL | -20,000 | $23.37 | 02/12/2026 | 02/17/2026 |
| Danahy Kevin Patrick | SELL | -20,000 | $1.53 | 02/12/2026 | 02/17/2026 |
| Danahy Kevin Patrick | SELL | -20,000 | $25.20 | 02/11/2026 | 02/11/2026 |
| Danahy Kevin Patrick | SELL | -20,000 | $1.53 | 02/11/2026 | 02/11/2026 |
| Danahy Kevin Patrick | SELL | -20,000 | $23.52 | 02/10/2026 | 02/11/2026 |